StonvexLoading…
StonvexStonvexStonvexCore line items from APG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.91B | $7.02B | $6.93B | $6.56B |
Operating Income | $554.00M | $484.00M | $359.00M | $162.00M |
Net Income | $302.00M | $250.00M | $153.00M | $73.00M |
EPS (Diluted) | $-0.69 | $-0.56 | $-0.46 | $0.10 |
Total Assets | $8.94B | $8.15B | $7.59B | $8.09B |
Total Liabilities | $5.53B | $5.20B | $4.72B | $5.17B |
Cash & Equivalents | $912.00M | $499.00M | $479.00M | $605.00M |
Free Cash Flow OCF − CapEx | $663.00M | $536.00M | $428.00M | $191.00M |
Shares Outstanding | 415.71M | 401.51M | 352.71M | 266.08M |